PTC Therapeutics Inc. buy JPMorgan Chase & Co.
Start price
20.06.24
/
50%
€31.20
Target price
20.06.25
€49.47
Performance (%)
35.26%
End price
21.06.25
€42.20
Summary
This prediction ended on 21.06.25 with a price of €42.20. The BUY prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc. saw massive gains of 35.26%. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| PTC Therapeutics Inc. | 3.451% | 3.451% | 60.000% |
| iShares Core DAX® | 0.224% | 1.487% | 3.575% |
| iShares Nasdaq 100 | 6.047% | 16.188% | 39.144% |
| iShares Nikkei 225® | 5.724% | 11.690% | 50.962% |
| iShares S&P 500 | 2.172% | 8.056% | 25.618% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its "overweight" rating re-affirmed by analysts at JPMorgan Chase & Co.. They now have a $53.00 price target on the stock.
Ratings data for PTCT provided by MarketBeat
In the thread Trading PTC Therapeutics Inc.
Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten
Stopped prediction by JPMorgan_Chase___Co_ for PTC Therapeutics Inc.
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€36.20
07.05.25
07.05.25
€59.06
07.05.26
07.05.26
61.22%
08.05.26
08.05.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€45.60
31.03.25
31.03.25
€69.18
31.03.26
31.03.26
28.29%
01.04.26
01.04.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€49.40
14.03.25
14.03.25
€71.90
14.03.26
14.03.26
14.37%
15.03.26
15.03.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€53.50
28.02.25
28.02.25
€69.21
28.02.26
28.02.26
6.54%
01.03.26
01.03.26
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€37.20
19.11.24
19.11.24
€58.53
19.11.25
19.11.25
78.76%
20.11.25
20.11.25
PTC Therapeutics Inc.
Start price
Target price
Perf. (%)
€35.00
21.05.24
21.05.24
€48.82
21.05.25
21.05.25
14.86%
22.05.25
22.05.25

